Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Oct;55(Suppl 2):S66–S69. doi: 10.1136/thorax.55.suppl_2.S66

The aspirin disease

D Schiavino, E Nucera, A Milani, M Del Ninno, A Buonomo, J Sun, G Patriarca
PMCID: PMC1765964  PMID: 10992564

Full Text

The Full Text of this article is available as a PDF (117.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown B. L., Harner S. G., Van Dellen R. G. Nasal polypectomy in patients with asthma and sensitivity to aspirin. Arch Otolaryngol. 1979 Jul;105(7):413–416. doi: 10.1001/archotol.1979.00790190039007. [DOI] [PubMed] [Google Scholar]
  2. Christie P. E., Smith C. M., Lee T. H. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis. 1991 Oct;144(4):957–958. doi: 10.1164/ajrccm/144.4.957. [DOI] [PubMed] [Google Scholar]
  3. Drazen J. M., Israel E., O'Byrne P. M. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999 Jan 21;340(3):197–206. doi: 10.1056/NEJM199901213400306. [DOI] [PubMed] [Google Scholar]
  4. Israel E., Fischer A. R., Rosenberg M. A., Lilly C. M., Callery J. C., Shapiro J., Cohn J., Rubin P., Drazen J. M. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1447–1451. doi: 10.1164/ajrccm/148.6_Pt_1.1447. [DOI] [PubMed] [Google Scholar]
  5. Jäntti-Alanko S., Holopainen E., Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinol Suppl. 1989;8:59–64. [PubMed] [Google Scholar]
  6. Knapp H. R., Sladek K., Fitzgerald G. A. Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med. 1992 Jan;119(1):48–51. [PubMed] [Google Scholar]
  7. Kowalski M. L. Management of aspirin-sensitive rhinosinusitis-asthma syndrome: what role for aspirin desensitization? Allergy Proc. 1992 Jul-Aug;13(4):175–184. doi: 10.2500/108854192778817202. [DOI] [PubMed] [Google Scholar]
  8. Nasser S. M., Bell G. S., Foster S., Spruce K. E., MacMillan R., Williams A. J., Lee T. H., Arm J. P. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Thorax. 1994 Aug;49(8):749–756. doi: 10.1136/thx.49.8.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Patriarca G., Bellioni P., Nucera E., Schiavino D., Papa G., Schinco G., Fais G., Pirotta L. R. Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis. Ann Allergy. 1991 Dec;67(6):588–592. [PubMed] [Google Scholar]
  10. Patriarca G., Nucera E., DiRienzo V., Schiavino D., Pellegrino S., Fais G. Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients. Ann Allergy. 1991 Jul;67(1):60–62. [PubMed] [Google Scholar]
  11. Patriarca G., Romano A., Schiavino D., Venuti A., Di Rienzo V., Fais G., Nucera E. ASA disease: the clinical relationship of nasal polyposis to ASA intolerance. Arch Otorhinolaryngol. 1986;243(1):16–19. doi: 10.1007/BF00457900. [DOI] [PubMed] [Google Scholar]
  12. Picado C., Castillo J. A., Montserrat J. M., Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J. 1989 Feb;2(2):127–129. [PubMed] [Google Scholar]
  13. SAMTER M. Nasal polyps: their relationship to allergy, particularly to bronchial asthma. Med Clin North Am. 1958 Jan;42(1):175–179. doi: 10.1016/s0025-7125(16)34334-6. [DOI] [PubMed] [Google Scholar]
  14. Samter M., Beers R. F., Jr Concerning the nature of intolerance to aspirin. J Allergy. 1967 Nov;40(5):281–293. doi: 10.1016/0021-8707(67)90076-7. [DOI] [PubMed] [Google Scholar]
  15. Sladek K., Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J. 1993 Mar;6(3):391–399. [PubMed] [Google Scholar]
  16. Stevenson D. D., Hankammer M. A., Mathison D. A., Christiansen S. C., Simon R. A. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996 Oct;98(4):751–758. doi: 10.1016/s0091-6749(96)70123-9. [DOI] [PubMed] [Google Scholar]
  17. Szczeklik A., Gryglewski R. J., Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol. 1977 Nov;60(5):276–284. doi: 10.1016/0091-6749(77)90106-3. [DOI] [PubMed] [Google Scholar]
  18. Szczeklik A., Stevenson D. D. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999 Jul;104(1):5–13. doi: 10.1016/s0091-6749(99)70106-5. [DOI] [PubMed] [Google Scholar]
  19. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J. 1990 May;3(5):588–593. [PubMed] [Google Scholar]
  20. WALTON C. H., RANDLE D. L. Aspirin allergy. Can Med Assoc J. 1957 Jun 15;76(12):1016–1018. [PMC free article] [PubMed] [Google Scholar]
  21. Weber R. W., Hoffman M., Raine D. A., Jr, Nelson H. S. Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol. 1979 Jul;64(1):32–37. doi: 10.1016/0091-6749(79)90080-0. [DOI] [PubMed] [Google Scholar]
  22. Yamamoto H., Nagata M., Kuramitsu K., Tabe K., Kiuchi H., Sakamoto Y., Yamamoto K., Dohi Y. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am J Respir Crit Care Med. 1994 Jul;150(1):254–257. doi: 10.1164/ajrccm.150.1.8025759. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES